SOBRsafe Regains Compliance with Nasdaq Listing Requirements
SOBRsafe (NASDAQ:SOBR) announced it has regained compliance with Nasdaq's listing requirements, including minimum bid price, public float, and stockholders' equity rules. The company will continue trading on The Nasdaq Capital Market under 'SOBR'. Following the October 30, 2024 compliance letter, SOBRsafe enters a mandatory one-year monitoring period. If found non-compliant with the Equity Rule during this period, the company will face immediate delisting procedures without a cure period, though it may request a new hearing.
SOBRsafe (NASDAQ:SOBR) ha annunciato di aver riconquistato la conformità ai requisiti di quotazione del Nasdaq, inclusi il prezzo minimo dell'offerta, il flottante pubblico e le regole relative all'equità degli azionisti. L'azienda continuerà a essere quotata sul Nasdaq Capital Market con il simbolo 'SOBR'. Dopo la lettera di conformità del 30 ottobre 2024, SOBRsafe entrerà in un periodo di monitoraggio obbligatorio di un anno. Se verrà trovata non conforme alla Regola di Equità durante questo periodo, l'azienda affronterà immediate procedure di delisting senza un periodo di riparazione, sebbene possa richiedere un nuovo audizione.
SOBRsafe (NASDAQ:SOBR) anunció que ha recuperado el cumplimiento de los requisitos de cotización de Nasdaq, incluidos el precio mínimo de oferta, el flotante público y las reglas sobre el patrimonio de los accionistas. La empresa continuará cotizando en el Nasdaq Capital Market bajo el símbolo 'SOBR'. Tras la carta de cumplimiento del 30 de octubre de 2024, SOBRsafe entrará en un período de monitoreo obligatorio de un año. Si se determina que no cumple con la Regla de Patrimonio durante este período, la empresa enfrentará procedimientos de delisting inmediatos sin un período de reparación, aunque puede solicitar una nueva audiencia.
SOBRsafe (NASDAQ:SOBR)는 최소 입찰 가격, 공적 유동성 및 주주 자본 규정을 포함하여 Nasdaq의 상장 요구 사항을 재확인했음을 발표했습니다. 회사는 'SOBR'이라는 이름으로 Nasdaq 자본 시장에서 거래를 계속할 것입니다. 2024년 10월 30일 준수 통지서 이후, SOBRsafe는 의무적인 1년 모니터링 기간에 들어갑니다. 이 기간 동안 자본 규정을 준수하지 않을 경우, 회사는 치료 기간 없이 즉각적인 상장 폐지 절차를 거치게 되며, 새로운 청문회를 요청할 수 있습니다.
SOBRsafe (NASDAQ:SOBR) a annoncé avoir retrouvé sa conformité aux exigences de cotation du Nasdaq, y compris le prix d'offre minimum, la flottabilité publique et les règles relatives aux capitaux propres des actionnaires. L'entreprise continuera à être négociée sur le Nasdaq Capital Market sous le symbole 'SOBR'. Suite à la lettre de conformité du 30 octobre 2024, SOBRsafe entre dans une période de surveillance obligatoire d'un an. Si elle est jugée non conforme à la règle des capitaux propres pendant cette période, l'entreprise fera face à des procédures de radiation immédiates sans période de remède, bien qu'elle puisse demander une nouvelle audience.
SOBRsafe (NASDAQ:SOBR) gab bekannt, dass es die Einhaltung der Listing-Anforderungen von Nasdaq, einschließlich der Mindestgebotspreise, der öffentlichen Streubesitz und der Vorschriften zum Eigenkapital der Aktionäre, wiederhergestellt hat. Das Unternehmen wird weiterhin unter dem Symbol 'SOBR' am Nasdaq Capital Market gehandelt. Nach dem Compliance-Brief vom 30. Oktober 2024 tritt SOBRsafe in einen Pflichtüberwachungszeitraum von einem Jahr ein. Sollte es in diesem Zeitraum nicht mit der Eigenkapitalregel konform gefunden werden, wird das Unternehmen sofortige Delisting-Verfahren ohne Heilungsfrist ausgesetzt, hat jedoch die Möglichkeit, eine neue Anhörung zu beantragen.
- Regained compliance with all Nasdaq listing requirements
- Maintains Nasdaq Capital Market listing status
- Risk of immediate delisting if equity requirements not met during one-year monitoring period
- No compliance plan or cure period allowed if future violations occur
Insights
This regulatory compliance achievement is significant for SOBRsafe's market standing. Meeting Nasdaq's listing requirements - particularly the minimum bid price, public float and stockholders' equity criteria - removes an immediate delisting threat. However, the mandatory one-year monitoring period presents ongoing risk. The company must maintain compliance across all metrics, with no second chances if equity requirements are breached again.
The stakes are particularly high given SOBRsafe's micro-cap status (
DENVER, CO / ACCESSWIRE / October 31, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today announced that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), the public float requirement under Nasdaq Listing Rule 5550(a)(4) and the stockholders' equity requirement (the "Equity Rule") under Nasdaq Listing Rule 5550(b)(1), as required by the Nasdaq Hearings Panel decision dated August 2024. Accordingly, the Company's common stock will continue to be listed and trade on The Nasdaq Capital Market under the symbol "SOBR".
The Company will be subject to a mandatory monitoring period of one year from the letter of compliance dated October 30, 2024 from the Nasdaq Listing Qualifications staff (the "Staff"). If within that one-year monitoring period, the Staff finds the Company again out of compliance with the Equity Rule, the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency and Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, nor will the company be afforded a cure or compliance period. Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing.
---
About SOBRsafe™
Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There has to be a better way.
Enter SOBRsafe™. Our advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration.
The SOBRsafe technology is commercially available for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). At SOBRsafe, our mission is to create better outcomes and save lives. To learn more, visit www.sobrsafe.com.
Contact SOBRsafe:
IR@sobrsafe.com
Safe Harbor Statement
Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. The Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing Sections. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.
SOURCE: SOBR Safe, Inc.
View the original press release on accesswire.com
FAQ
What requirements did SOBRsafe (SOBR) regain compliance with on Nasdaq?
How long is SOBRsafe's (SOBR) mandatory monitoring period after regaining Nasdaq compliance?